Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E28.08 EPS (ttm)6.79 Insider Own11.70% Shs Outstand908.04M Perf Week4.43%
Market Cap179.58B Forward P/E21.81 EPS next Y8.74 Insider Trans-0.75% Shs Float856.60M Perf Month3.43%
Income6.19B PEG2.32 EPS next Q2.14 Inst Own83.50% Short Float0.90% Perf Quarter-3.97%
Sales24.54B P/S7.32 EPS this Y36.90% Inst Trans7.20% Short Ratio1.94 Perf Half Y30.45%
Book/sh6.21 P/B30.69 EPS next Y4.80% ROA14.30% Target Price215.74 Perf Year20.80%
Cash/sh3.91 P/C48.78 EPS next 5Y12.10% ROE140.40% 52W Range129.21 - 218.00 Perf YTD12.89%
Dividend3.40 P/FCF74.06 EPS past 5Y24.60% ROI22.60% 52W High-12.56% Beta0.25
Dividend %1.78% Quick Ratio1.10 Sales past 5Y4.20% Gross Margin77.70% 52W Low47.52% ATR3.71
Employees35000 Current Ratio1.40 Sales Q/Q21.70% Oper. Margin24.70% RSI (14)55.46 Volatility1.75% 1.64%
OptionableYes Debt/Eq2.94 EPS Q/Q41.70% Profit Margin25.20% Rel Volume0.62 Prev Close189.64
ShortableYes LT Debt/Eq2.94 EarningsApr 27 BMO Payout43.40% Avg Volume3.97M Price190.61
Recom2.20 SMA203.28% SMA50-2.07% SMA20013.99% Volume2,460,035 Change0.51%
Jan-19-21Upgrade Mizuho Neutral → Buy $164 → $222
Dec-10-20Upgrade Wolfe Research Peer Perform → Outperform $147 → $183
Nov-10-20Resumed Bernstein Mkt Perform $150
Sep-29-20Initiated Berenberg Hold $144
Sep-03-20Upgrade Morgan Stanley Equal-Weight → Overweight $176
Jun-16-20Upgrade Guggenheim Neutral → Buy
Apr-21-20Downgrade UBS Buy → Neutral $157 → $158
Apr-09-20Downgrade Morgan Stanley Overweight → Equal-Weight $148
Feb-06-20Initiated Mizuho Neutral
Dec-18-19Upgrade Morgan Stanley Equal-Weight → Overweight $116 → $150
Oct-17-19Resumed BofA/Merrill Buy $133
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Apr-20-21 06:45AM  
Apr-19-21 10:24AM  
09:54AM  
Apr-17-21 08:42AM  
Apr-16-21 07:14AM  
07:03AM  
06:51AM  
06:48AM  
06:30AM  
04:24AM  
Apr-13-21 12:44PM  
06:30AM  
Apr-12-21 12:53PM  
08:31AM  
07:41AM  
07:16AM  
06:54AM  
06:45AM  
Apr-11-21 02:00PM  
Apr-10-21 07:03AM  
Apr-09-21 02:15PM  
09:55AM  
09:51AM  
08:43AM  
07:34AM  
06:30AM  
Apr-08-21 07:41AM  
07:01AM  
06:45AM  
Apr-07-21 07:29AM  
Apr-06-21 04:30PM  
02:30PM  
Apr-02-21 12:40PM  
Apr-01-21 08:00AM  
Mar-31-21 08:30AM  
07:31AM  
Mar-30-21 09:01AM  
Mar-29-21 09:32AM  
09:05AM  
08:44AM  
08:30AM  
07:12AM  
Mar-27-21 01:19PM  
07:21AM  
Mar-26-21 09:53AM  
07:55AM  
12:07AM  
Mar-25-21 04:12PM  
11:50AM  
08:45AM  
Mar-24-21 07:01AM  
Mar-23-21 05:50PM  
08:27AM  
04:17AM  
Mar-22-21 04:51PM  
01:09PM  
05:10AM  
Mar-21-21 11:18AM  
Mar-19-21 10:30AM  
Mar-18-21 09:39AM  
08:38AM  
08:05AM  
Mar-17-21 08:47AM  
06:45AM  
06:04AM  
Mar-16-21 12:27PM  
11:20AM  
09:30AM  
08:38AM  
07:35AM  
07:06AM  
06:45AM  
Mar-15-21 04:52PM  
04:31PM  
12:14PM  
11:24AM  
10:11AM  
08:32AM  
07:54AM  
07:47AM  
07:44AM  
07:14AM  
04:55AM  
04:44AM  
02:56AM  
Mar-13-21 06:43AM  
06:30AM  
06:30AM  
06:30AM  
Mar-12-21 05:52PM  
12:23PM  
11:19AM  
09:33AM  
06:37AM  
Mar-11-21 04:18PM  
09:13AM  
08:38AM  
07:13AM  
07:09AM  
05:28AM  
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products worldwide. It offers Baqsimi for severe hypoglycemia; Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500, and Lyumjev for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company also provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+ and HER2- metastatic breast cancer. In addition, it offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Further, the company Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; Reyvow for migraine; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Additionally, it Bamlanivimab and etesevimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; AbCellera Biologics Inc.; and Junshi Biosciences. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerMar 09Sale209.7959,95912,579,032110,302,100Mar 10 02:59 PM
LILLY ENDOWMENT INC10% OwnerMar 08Sale209.69125,28426,271,092110,362,059Mar 09 12:26 PM
Hakim AnatSVP, GC & SecretaryMar 01Option Exercise0.007,92807,928Mar 03 05:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.005,445027,425Feb 03 06:29 PM
Shah Aarti S.SVP & CIDOFeb 01Option Exercise0.006,282023,369Feb 03 07:02 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0075,3870343,639Feb 03 06:57 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0016,754035,400Feb 03 07:26 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Feb 01Option Exercise0.006,282010,592Feb 03 06:51 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.0012,146056,919Feb 03 06:43 PM
Norton JohnaSenior VP, Global QualityFeb 01Option Exercise0.003,435020,953Feb 03 06:38 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0015,0780115,289Feb 03 06:33 PM
Smiley Joshua LSVP and CFOFeb 01Option Exercise0.0019,266060,702Feb 03 08:22 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale190.80215,00041,022,862110,487,343Jan 19 01:04 PM
LILLY ENDOWMENT INC10% OwnerJan 13Sale185.97210,00039,053,064110,702,343Jan 14 11:23 AM
LILLY ENDOWMENT INC10% OwnerJan 11Sale185.49220,00040,807,754110,912,343Jan 12 11:27 AM
Smiley Joshua LSVP and CFOOct 01Option Exercise0.007,947044,918Oct 05 12:19 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMSep 08Sale151.015,000755,05023,580Sep 10 04:25 PM
Mason Michael BSr. VP & Pres., Lilly DiabetesSep 01Option Exercise0.006,244021,279Sep 02 05:04 PM
Fry Stephen FSVP, HR & DiversityAug 17Sale150.647,2041,085,211100,211Aug 18 03:31 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJul 09Sale170.0011,0001,870,00018,646Jul 13 01:43 PM
LILLY ENDOWMENT INC10% OwnerJul 09Sale169.6912,9612,199,392111,132,343Jul 10 02:16 PM
LILLY ENDOWMENT INC10% OwnerJul 07Sale167.29210,00035,131,799111,145,304Jul 08 12:49 PM
LILLY ENDOWMENT INC10% OwnerJul 06Sale166.99205,00034,232,086111,379,612Jul 07 02:27 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,46805,424Jul 06 04:50 PM
LILLY ENDOWMENT INC10% OwnerJun 30Sale163.20166,83227,227,760111,560,304Jul 01 11:17 AM
LILLY ENDOWMENT INC10% OwnerJun 29Sale163.3911,4311,867,760111,727,136Jun 30 03:12 PM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jul 01 09:55 AM
LILLY ENDOWMENT INC10% OwnerJun 26Sale163.0131,7375,173,404111,738,567Jun 30 02:48 PM
LILLY ENDOWMENT INC10% OwnerJun 18Sale161.5453,7708,686,046111,770,304Jun 19 02:21 PM
LILLY ENDOWMENT INC10% OwnerJun 17Sale161.38161,23026,019,469111,824,074Jun 18 05:16 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 16Sale162.9417,0002,770,00029,646Jun 18 09:36 AM
LILLY ENDOWMENT INC10% OwnerJun 16Sale162.92212,33734,593,145111,985,304Jun 17 03:13 PM
Zulueta Alfonso GSVP & President, Lilly Int'lJun 05Sale150.0010,0001,500,00046,646Jun 09 04:52 PM
LILLY ENDOWMENT INC10% OwnerApr 27Sale163.6012,6632,071,715112,197,641Apr 28 12:21 PM
LILLY ENDOWMENT INC10% OwnerApr 24Sale162.47220,00035,743,218112,210,304Apr 27 02:36 PM
LILLY ENDOWMENT INC10% OwnerApr 23Sale160.12230,00036,826,587112,430,304Apr 27 10:39 AM